LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
about
Non-invasive diagnosis of liver fibrosis and cirrhosis.Liver fibrosis markers of nonalcoholic steatohepatitis.A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients.Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.Lectin microarrays: concept, principle and applications.Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics.Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.Serum WFA(+) -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
P2860
Q26778033-4D30EB46-EB5F-4A4E-B7BF-C981B8B1B537Q30407625-683FB6DD-0443-4E13-9E0F-7E3958B4C86CQ30459124-5506191F-B5A2-4558-9C8B-C11269E11252Q33655116-C5E60519-9C01-4B4C-9DA7-461207803E87Q34769512-A1ECA4F6-7724-4B5C-8077-23DD8974711CQ34785324-3ABFEA96-2B79-4D0E-890B-DBD89CB316A3Q38084836-9248A5CA-D91E-48F5-850D-4E2D790A9071Q38591154-DC5F07D4-018C-4B74-A669-2EC93D1EF669Q39138238-C02A659A-3BAF-4C64-ABA0-E700B30C3C7AQ40244120-76997D05-53BB-4C92-983A-97EA1E550658Q47259004-F7B4407E-D76C-4B45-835E-1FFB5C6B9546Q55353688-02B76E33-E930-497C-929E-DDD96194D6BA
P2860
LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@en
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@nl
type
label
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@en
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@nl
prefLabel
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@en
LecT-Hepa, a glyco-marker deri ...... chronic hepatitis C patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
LecT-Hepa, a glyco-marker deri ...... n chronic hepatitis C patients
@en
P2093
Hiroaki Saito
Kazumoto Murata
Kiyoaki Ito
Masaaki Korenaga
Masashi Mizokami
Masatoshi Imamura
Masaya Sugiyama
Masayoshi Kage
Masayuki Kurosaki
Michiie Sakamoto
P2860
P304
P356
10.1002/HEP.25815
P407
P577
2012-10-01T00:00:00Z